<?xml version="1.0" encoding="UTF-8"?>
<p>Vaccines against COVID-19 are being pursued. Researchers report that the timeline has been compressed to 3.25 months for a phase I trial, using messenger RNA technologies [
 <xref ref-type="bibr" rid="CR2">2</xref>]. Other groups are attempting to construct vaccines using viral vectors and vaccines directed at subunits [
 <xref ref-type="bibr" rid="CR2">2</xref>]. Despite worldwide efforts to identify methods to prevent and treat COVID-19, a recent comprehensive review concluded “No therapies have been shown effective to date” [
 <xref ref-type="bibr" rid="CR26">26</xref>].
</p>
